X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The net proceeds will enable Atavistik to advance its lead precision allosteric small molecule therapeutic in oncology into the clinic and to advance its earlier stage pipeline.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Small molecule
Partner/Sponsor/Collaborator: The Column Group
Deal Size: $40.0 million Upfront Cash: Undisclosed
Deal Type: Financing December 19, 2023
Details:
Atavistik Bio will enhance its proprietary Interactome map with Plex Research’s cloud-based AI-powered drug discovery search engine of large and disparate data sources to reveal hidden connections between related metabolites and ligands.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Discovery PlatformProduct Type: Small molecule
Partner/Sponsor/Collaborator: Plex Research
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration January 10, 2023
Details:
The financing will support development of Atavastik’s drug discovery platform, and future identification of select drug candidates based on knowledge of disease relevant pathways that have evolved over millions of years by nature to be allosterically regulated by metabolites.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Discovery PlatformProduct Type: Undisclosed
Partner/Sponsor/Collaborator: The Column Group
Deal Size: $60.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing August 24, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
